170 related articles for article (PubMed ID: 20673724)
21. Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.
Huang H; Silverman RB
Curr Top Med Chem; 2013; 13(7):803-12. PubMed ID: 23578024
[TBL] [Abstract][Full Text] [Related]
22. Structures of human constitutive nitric oxide synthases.
Li H; Jamal J; Plaza C; Pineda SH; Chreifi G; Jing Q; Cinelli MA; Silverman RB; Poulos TL
Acta Crystallogr D Biol Crystallogr; 2014 Oct; 70(Pt 10):2667-74. PubMed ID: 25286850
[TBL] [Abstract][Full Text] [Related]
23. Chiral linkers to improve selectivity of double-headed neuronal nitric oxide synthase inhibitors.
Jing Q; Li H; Chreifi G; Roman LJ; Martásek P; Poulos TL; Silverman RB
Bioorg Med Chem Lett; 2013 Oct; 23(20):5674-9. PubMed ID: 23993333
[TBL] [Abstract][Full Text] [Related]
24. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
25. The discovery of potentially selective human neuronal nitric oxide synthase (nNOS) Inhibitors: a combination of pharmacophore modelling, CoMFA, virtual screening and molecular docking studies.
Xu G; Chen Y; Shen K; Wang X; Li F; He Y
Int J Mol Sci; 2014 May; 15(5):8553-69. PubMed ID: 24830557
[TBL] [Abstract][Full Text] [Related]
26. Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors.
Ji H; Stanton BZ; Igarashi J; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Am Chem Soc; 2008 Mar; 130(12):3900-14. PubMed ID: 18321097
[TBL] [Abstract][Full Text] [Related]
27. Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.
Li H; Xue F; Kraus JM; Ji H; Labby KJ; Mataka J; Delker SL; Martásek P; Roman LJ; Poulos TL; Silverman RB
Bioorg Med Chem; 2013 Mar; 21(5):1333-43. PubMed ID: 23352768
[TBL] [Abstract][Full Text] [Related]
28. Pharmacophore and QSAR Modeling of Neuronal Nitric Oxide Synthase Ligands and Subsequent Validation and In Silico Search for New Scaffolds.
Suaifan G; Shehadeh M; Al-Ijel H; Al-Jamal KT; Taha M
Med Chem; 2016; 12(4):371-93. PubMed ID: 26427928
[TBL] [Abstract][Full Text] [Related]
29. Potent, highly selective, and orally bioavailable gem-difluorinated monocationic inhibitors of neuronal nitric oxide synthase.
Xue F; Li H; Delker SL; Fang J; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Am Chem Soc; 2010 Oct; 132(40):14229-38. PubMed ID: 20843082
[TBL] [Abstract][Full Text] [Related]
30. Hydroxyl-terminated peptidomimetic inhibitors of neuronal nitric oxide synthase.
Mbadugha BN; Seo J; Ji H; Martásek P; Roman LJ; Shea TM; Li H; Poulos TL; Silverman RB
Bioorg Med Chem; 2006 Jun; 14(11):3681-90. PubMed ID: 16480878
[TBL] [Abstract][Full Text] [Related]
31. Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors.
Cinelli MA; Li H; Chreifi G; Poulos TL; Silverman RB
J Med Chem; 2017 May; 60(9):3958-3978. PubMed ID: 28422508
[TBL] [Abstract][Full Text] [Related]
32. Combination of chiral linkers with thiophenecarboximidamide heads to improve the selectivity of inhibitors of neuronal nitric oxide synthase.
Jing Q; Li H; Roman LJ; Martásek P; Poulos TL; Silverman RB
Bioorg Med Chem Lett; 2014 Sep; 24(18):4504-4510. PubMed ID: 25149509
[TBL] [Abstract][Full Text] [Related]
33. Hydroxyethylene isosteres of selective neuronal nitric oxide synthase inhibitors.
Erdal EP; Martásek P; Roman LJ; Silverman RB
Bioorg Med Chem; 2007 Sep; 15(18):6096-108. PubMed ID: 17614291
[TBL] [Abstract][Full Text] [Related]
34. Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors.
Pensa AV; Cinelli MA; Li H; Chreifi G; Mukherjee P; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2017 Aug; 60(16):7146-7165. PubMed ID: 28776992
[TBL] [Abstract][Full Text] [Related]
35. Screening of novel and selective inhibitors for neuronal nitric oxide synthase (nNOS) via structure-based drug design techniques.
Boumezber S; Yelekçi K
J Biomol Struct Dyn; 2023 May; 41(8):3607-3629. PubMed ID: 35322764
[TBL] [Abstract][Full Text] [Related]
36. Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.
Wang HY; Qin Y; Li H; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2016 May; 59(10):4913-25. PubMed ID: 27050842
[TBL] [Abstract][Full Text] [Related]
37. Structural Basis for Isoform Selective Nitric Oxide Synthase Inhibition by Thiophene-2-carboximidamides.
Li H; Evenson RJ; Chreifi G; Silverman RB; Poulos TL
Biochemistry; 2018 Nov; 57(44):6319-6325. PubMed ID: 30335983
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group.
Carrión MD; Chayah M; Entrena A; López A; Gallo MA; Acuña-Castroviejo D; Camacho ME
Bioorg Med Chem; 2013 Jul; 21(14):4132-42. PubMed ID: 23735830
[TBL] [Abstract][Full Text] [Related]
39. Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold.
Do HT; Li H; Chreifi G; Poulos TL; Silverman RB
J Med Chem; 2019 Mar; 62(5):2690-2707. PubMed ID: 30802056
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
Flinspach ML; Li H; Jamal J; Yang W; Huang H; Hah JM; Gómez-Vidal JA; Litzinger EA; Silverman RB; Poulos TL
Nat Struct Mol Biol; 2004 Jan; 11(1):54-9. PubMed ID: 14718923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
